Core Viewpoint - The medical health industry in China is expected to experience stable and continuous growth driven by innovation, supportive policies, and a return to a market pricing system based on clinical value and demand, leading to a positive outlook for listed companies [1] Summary by Categories Investment Trends - By 2026, the pharmaceutical investment trend will be influenced by the concentration of innovation in Chinese pharmaceutical companies and a series of supportive policies aimed at promoting innovative drugs and medical devices, optimizing procurement, and enhancing commercial insurance [1] Market Environment - The medical health industry is anticipated to gradually return to a pricing system that reflects clinical value and demand, fostering a stable domestic pharmaceutical market environment and a long-term growth trajectory for the industry [1] Performance Outlook - Listed companies in the pharmaceutical sector are expected to see sustained and stable performance growth, contributing to a certain degree of industry growth certainty [1] Investment Strategies - Recommended investment strategies for 2026 include: 1. Focus on innovation-driven and internationalization efforts, particularly in the context of a "de-involution" domestic policy environment [1] 2. Emphasize self-sufficiency and the acceleration of import substitution processes for core components, reagents, and upstream research due to potential geopolitical risks [1] 3. Identify beneficiaries of policy changes such as optimized procurement, three-payment systems in medical insurance, consumer stimulus policies, and state-owned enterprise reforms [1]

Core Viewpoint - The successful launch of the Shenzhou 21 manned spacecraft highlights the critical role of Sichuan Huafeng Technology Co., Ltd., a subsidiary of Changhong Holding Group, in providing high-speed connectors for data transmission and astronaut monitoring [1][3] Group 1: Breakthroughs in Technology - The "Seventh Project" was initiated to overcome the monopolistic control of international giants in the high-speed backplane connector market, which had posed a supply risk to the domestic communications industry [5] - Within a year, the company developed and mass-produced a 10Gbps high-speed backplane connector, effectively breaking the foreign monopoly that had taken international competitors a decade to establish [5][6] - By 2020, the company achieved customer certification for a 56Gbps connector, further eliminating foreign dominance in the 56G and below speed range, and has since developed a 112Gbps product that is now in mass production [6] Group 2: Strategic Initiatives - The launch of the "A Plan" signifies the company's transition from a high-speed connector manufacturer to a provider of complete high-speed interconnection solutions, addressing the evolving market demand driven by 6G and AI technologies [8] - The "A Plan" aims to create a comprehensive solution encompassing components, modules, and systems, thereby expanding the application boundaries of "Chinese chips" [8] Group 3: Talent Development - The company has established a robust talent cultivation system, with a focus on practical experience and innovation, ensuring that every researcher can grow and contribute effectively [10] - As of June 2025, the proportion of R&D personnel in the company reached 31.68%, reflecting a year-on-year increase of 6.79%, with a diverse range of expertise in fields such as electronic precision mechanics and software engineering [11] - The implementation of the "Wutong Plan" for talent recruitment has successfully attracted 141 talents, including 15 with master's or doctoral degrees, enhancing the company's innovation capabilities [11] Group 4: Future Outlook - The company is committed to maintaining a minimum of 10% of its revenue for R&D each year, focusing on technological iteration to drive product upgrades and establish industry benchmarks in complex system interconnection and high-speed data transmission [12] - With the deep integration of 6G, AI, and aerospace, the company aims to continue safeguarding the "Chinese Dream" with its innovations in high-end manufacturing [12]

Core Viewpoint - The pharmaceutical industry in China is expected to maintain a stable and continuous growth trend, driven by innovation and supportive policies, leading to a return to a market pricing system based on clinical value and demand [1] Group 1: Investment Trends - By 2026, the medical health industry is anticipated to benefit from a series of supportive policies for innovative drugs and medical devices, optimization of centralized procurement, and promotion of commercial insurance [1] - The industry is expected to experience a stable domestic market environment and a long-term growth trajectory, providing certainty for industry growth [1] Group 2: Investment Recommendations - Focus on innovation-driven and internationalization strategies, particularly in the context of domestic policy changes that discourage internal competition [1] - Emphasize on self-sufficiency, particularly in core components, reagents, and upstream research areas, to mitigate risks from geopolitical disturbances [1] - Identify opportunities related to new policies, including benefits from optimized centralized procurement, three-payment systems in medical insurance, consumer stimulus policies, and state-owned enterprise reforms [1]

Core Viewpoint - The establishment of a "self-controllable" cross-border payment system for the Renminbi (RMB) is crucial for ensuring financial security, supporting the internationalization of the RMB, and enhancing China's international financial influence [1][3]. Group 1: Current Challenges in Cross-Border Payments - Cross-border payments face issues such as high costs, low efficiency, lack of transparency, and limited access, primarily due to long payment chains, high compliance costs, and insufficient trust among entities [1]. - The RMB's share in global foreign exchange reserves remains significantly lower than that of the US dollar and euro, indicating substantial room for growth in the RMB's internationalization [2]. Group 2: Strategic Focus for RMB Payment System Development - Key areas for developing a self-controllable RMB cross-border payment system include expanding network coverage, optimizing institutional rules, exploring cutting-edge technologies, and strengthening application scenarios [3]. - The Cross-Border Interbank Payment System (CIPS) is positioned as a vital component for enhancing the global influence of the RMB cross-border payment system [3]. Group 3: Role of Digital Currency - The application of Central Bank Digital Currency (CBDC) enhances the efficiency and security of RMB cross-border payments and helps mitigate sanctions risks arising from geopolitical conflicts [4]. - Developing a robust offshore RMB market ecosystem is essential for the RMB cross-border payment system, which includes promoting RMB-denominated investment tools in major offshore markets [4].

Core Viewpoint - Nomura emphasizes China's focus on resilient, stable, and inclusive economic growth from 2026 to 2030, driven by significant investments and industrial policies, particularly in the semiconductor and AI sectors [2][6]. Group 1: Economic Outlook - Global economy shows significant resilience despite challenges such as rising tariffs and geopolitical tensions, supported by AI transformation and flexible trade adjustments [4]. - Asia (excluding Japan) is expected to face a challenging external environment while maintaining strong performance in the tech sector, driven by AI demand and a supercycle in storage chips [5]. - China's economic growth remains steady, but potential challenges include weak domestic demand and rising global trade barriers [8]. Group 2: A-Share Market Dynamics - Policy support, liquidity, and industrial upgrades are identified as core drivers for the future rise of A-shares, with AI and high-value exports being key themes for the upcoming year [6][2]. - Despite high valuations in A-shares, the equity risk premium remains reasonable, indicating potential for continued market support [6]. Group 3: AI and Technology Sector - The trend towards a self-sufficient AI supply chain in China is becoming increasingly evident, with significant investments in AI infrastructure and the development of large language models [10][11]. - The internet sector's focus will remain on strategic investments in AI by leading platforms and the competitive landscape in instant retail, with expectations of reduced competition intensity in the fourth quarter [11]. Group 4: Policy and Investment Focus - The Chinese government is likely to shift its policy focus towards stabilizing growth and alleviating price pressures, with fiscal expansion becoming a key agenda item [8].

Core Insights - Nomura emphasizes China's focus on resilient, stable, and inclusive economic growth from 2026 to 2030, driven by significant investments and industrial policies, particularly in semiconductors and artificial intelligence [1][5] - The core drivers for the A-share market's future growth are policy support, liquidity, and industrial upgrades, with AI and high-value exports identified as key themes for the upcoming year [4][1] Group 1: Global Economic Resilience - Despite rising tariffs, geopolitical tensions, and fiscal pressures, the global economy shows significant resilience, supported by the AI revolution, flexible trade adjustments, and moderate monetary and fiscal policies [2] - Economic inequality is becoming more pronounced, with low-income families and small businesses struggling, posing challenges for policymakers to maintain global economic stability [2] Group 2: Asian Economic Outlook - The technology sector in Asia (excluding Japan) is expected to perform well, driven by strong demand for AI and a supercycle in storage chips, while non-tech sectors face challenges due to limited spillover effects from AI and increased tariffs on labor-intensive industries [3] - The region's solid economic fundamentals and new growth drivers, such as supply chain shifts and increased AI investment, position India, the Philippines, and Malaysia as some of the fastest-growing economies in the next decade [3] Group 3: A-share Market Dynamics - A-share valuations have expanded over the past year but remain reasonable when considering the equity risk premium in a declining risk-free rate environment [4] - The "14th Five-Year Plan" emphasizes long-term productivity upgrades and technological transformation, which will catalyze structural market trends, although improvements in earnings fundamentals are still needed [4][7] Group 4: AI and Technology Sector Developments - The trend towards a self-sufficient AI supply chain in China is becoming more evident, with significant investments in AI infrastructure and a focus on developing large language models and generative AI applications [8] - The competitive landscape in the instant retail sector is expected to stabilize, potentially alleviating losses for companies expanding in this area [8] Group 5: Entertainment Sector Insights - The online entertainment sector, particularly online gaming and music services, is expected to remain resilient, while long-form video content may continue to lag due to shifts in consumer preferences towards short videos [9]

Core Viewpoint - The article highlights the significant progress of Jiangsu Suzhou's leading MEMS probe card company, Qiangyi Co., in its IPO process on the Sci-Tech Innovation Board, emphasizing its role in the semiconductor industry and the necessity for domestic probe card production to reduce reliance on foreign suppliers [2][3]. Industry Overview - The semiconductor industry in China has a late start and still relies heavily on imports for chip design and wafer manufacturing, leading to a lag in the domestic probe card industry [2]. - The top ten probe card manufacturers globally are predominantly foreign companies, holding over 80% of the market share, indicating a substantial self-sufficiency gap for domestic manufacturers [2]. Company Positioning - Qiangyi Co. is the only domestic company to enter the global top ten in the semiconductor probe card industry, covering various core participants in the domestic chip design, wafer foundry, and packaging testing sectors [3]. - The company aims to enhance its R&D capabilities and MEMS probe card production capacity through funds raised from its IPO, aligning with the growth of China's semiconductor manufacturing capabilities [3]. Product and Market Strategy - The company’s probe card products are primarily used in non-storage fields, including SoC chips, CPUs, GPUs, and RF chips, with a market share in the non-storage sector expected to remain between 60%-75% from 2018 to 2024 [3]. - Qiangyi Co. is actively expanding into the storage sector, developing 2.5D MEMS probe cards for HBM and NAND Flash applications, focusing on key domestic players like Company B, Hefei Changxin, and Yangtze Memory Technologies [3][4]. Financial Performance - The company has experienced rapid growth, with a compound annual growth rate (CAGR) of 58.85% in revenue, reflecting its strong market position and customer recognition [4]. Future Outlook - The domestic probe card manufacturers are expected to benefit from the rapid development of the semiconductor industry and the acceleration of domestic substitution processes [5]. - Qiangyi Co. plans to enhance its product offerings in MEMS probe cards, focusing on increasing market share in 2D MEMS probe cards and scaling up production of thin-film and 2.5D/3D MEMS probe cards [5][6]. - The company aims to achieve breakthroughs in technology, including reaching a testing frequency of 110GHz for thin-film probe cards and developing 3D MEMS probe cards for DRAM chips [6].

Core Viewpoint - The report from CITIC Securities indicates a structural prosperity in the mechanical industry despite relatively weak domestic demand, with a focus on new technologies and identifying beneficiaries from interest rate cuts and manufacturing capacity transfers [1][2]. Group 1: Focus on New Technologies - Emphasis on emerging industries with intensive technological changes and strong capital expenditures, such as humanoid robots, solid-state battery equipment, controllable nuclear fusion, and PCB equipment [1][3]. - The humanoid robot sector is expected to see significant advancements, with major companies like Tesla and Nvidia making substantial investments, marking 2026 as a pivotal year for mass production [3]. - The lithium battery equipment sector is showing signs of recovery after a two-year downturn, with improvements in revenue and profit, driven by new technologies [3]. Group 2: Seeking New Growth - The engineering machinery sector is recovering, with various categories showing growth, particularly in non-excavation machinery, supported by favorable export trends [4]. - The tools and hardware sector is expected to benefit from improved US-China relations and tariff reductions in the short term, with long-term gains anticipated from real estate demand following US interest rate cuts [4]. - The mining machinery sector is experiencing increased capital expenditures due to rising non-ferrous metal prices, with domestic companies expanding their overseas presence [4].

Group 1 - The core viewpoint of the report is that the chemical industry is approaching a cyclical turning point, with a slowdown in capital expenditure and the implementation of counter-cyclical policies expected to boost domestic demand recovery [1] - The report suggests focusing on sectors that will benefit from supply-side improvements and domestic demand, including polyurethane (Wanhua Chemical), coal chemical (Baofeng Energy, Hualu Hengsheng), petrochemicals (Satellite Chemical, Hengli Petrochemical, Rongsheng Petrochemical), polyester filament (Xinfengming, Tongkun Co.), phosphorus chemicals (Chuanheng Co.), fluorine chemicals (Juhua Co., Sanmei Co., Dongyue Group), silicon chemicals (Hesheng Silicon Industry), spandex (Huafeng Chemical), and pesticides (Jiangshan Co., Xingfa Group) [1] Group 2 - New materials remain a primary development direction for China's chemical industry, with key areas of focus including industrial new demands driven by humanoid robots and policy-driven new demands such as bio-aviation fuel [2] - The report highlights the importance of high shareholder returns as a means for quality enterprises to reshape investment value, with examples including CNOOC, PetroChina, Sinopec, and companies in the phosphorus chemical sector like Chuanheng Co. and Yuntianhua [2]

Core Viewpoint - Guohai Securities maintains a "Buy" rating on Huahong Semiconductor (01347), citing the company's growth in wafer volume and price under the trend of self-control and "China for China" [1] Group 1: Financial Performance - In Q3 2025, Huahong Semiconductor reported revenue of $635 million, a quarter-over-quarter increase of 12.2% and a year-over-year increase of 20.7% [2] - The company achieved a gross margin of 13.5%, up 2.6 percentage points quarter-over-quarter and 1.3 percentage points year-over-year, exceeding guidance of 10%-12% [2] - Net profit attributable to shareholders was $26 million, reflecting a significant quarter-over-quarter increase of 223.5% but a year-over-year decrease of 42.6% [2] Group 2: Future Guidance - For Q4 2025, Huahong Semiconductor expects revenue between $650 million and $660 million, representing a quarter-over-quarter increase of 3.1% and a year-over-year increase of 21.5% [3] - The company anticipates a gross margin of 12%-14% for Q4, which is above market expectations [3] - Revenue growth is expected to be driven by collaborations with "China-for-China" strategic customers and the gradual release of Fab9A capacity [3] Group 3: Investment Forecast - Huahong Semiconductor's revenue projections for 2025, 2026, and 2027 are $2.4 billion, $3.03 billion, and $3.35 billion, respectively, with net profits of $90 million, $194 million, and $263 million [4] - The diluted EPS for the same years is projected to be $0.05, $0.11, and $0.17, respectively [4] - The price-to-book ratio for November 10, 2025, is expected to be 2.74x, 2.66x, and 2.31x for the respective years [4]